USANA Health Sciences (NYSE:USNA) Reaches New 1-Year Low – Should You Sell?

USANA Health Sciences, Inc. (NYSE:USNA)’s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as $27.58 and last traded at $28.03, with a volume of 59771 shares traded. The stock had previously closed at $27.98.

Analyst Ratings Changes

A number of equities research analysts have issued reports on USNA shares. DA Davidson decreased their price objective on USANA Health Sciences from $38.00 to $36.00 and set a “neutral” rating on the stock in a research report on Thursday, February 27th. StockNews.com cut USANA Health Sciences from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 14th. Finally, Sidoti cut USANA Health Sciences from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, February 18th.

USANA Health Sciences Trading Down 1.1 %

The company has a market capitalization of $514.92 million, a price-to-earnings ratio of 9.62, a P/E/G ratio of 0.93 and a beta of 0.98. The firm has a 50-day simple moving average of $32.09 and a two-hundred day simple moving average of $35.63.

USANA Health Sciences (NYSE:USNA) last released its quarterly earnings results on Tuesday, February 25th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.49 by $0.15. The firm had revenue of $213.61 million for the quarter, compared to analyst estimates of $208.82 million. USANA Health Sciences had a net margin of 6.30% and a return on equity of 10.64%. Equities research analysts anticipate that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.

Insider Activity at USANA Health Sciences

In other USANA Health Sciences news, insider David Mulham Mulham sold 3,234 shares of the company’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $32.98, for a total transaction of $106,657.32. Following the transaction, the insider now directly owns 12,775 shares in the company, valued at approximately $421,319.50. This represents a 20.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Joshua Foukas sold 5,732 shares of the firm’s stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $32.54, for a total transaction of $186,519.28. The disclosure for this sale can be found here. Insiders sold a total of 15,920 shares of company stock valued at $500,285 over the last ninety days. Insiders own 0.33% of the company’s stock.

Institutional Investors Weigh In On USANA Health Sciences

A number of large investors have recently added to or reduced their stakes in USNA. Martingale Asset Management L P boosted its holdings in shares of USANA Health Sciences by 2.1% in the 3rd quarter. Martingale Asset Management L P now owns 16,732 shares of the company’s stock valued at $634,000 after buying an additional 340 shares during the period. KBC Group NV raised its position in shares of USANA Health Sciences by 96.6% during the 3rd quarter. KBC Group NV now owns 1,056 shares of the company’s stock worth $40,000 after buying an additional 519 shares in the last quarter. R Squared Ltd acquired a new stake in USANA Health Sciences during the fourth quarter valued at approximately $28,000. Safe Harbor Fiduciary LLC acquired a new stake in USANA Health Sciences during the third quarter valued at approximately $30,000. Finally, Exchange Traded Concepts LLC lifted its stake in USANA Health Sciences by 11.3% during the fourth quarter. Exchange Traded Concepts LLC now owns 8,578 shares of the company’s stock valued at $308,000 after purchasing an additional 869 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.